{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:54:39Z","timestamp":1783457679960,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2016.04.060","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T07:33:34Z","timestamp":1466840014000},"page":"6610-6616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains"],"prefix":"10.1016","volume":"34","author":[{"given":"Richard C.","family":"Condit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lise","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sheets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Seligman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Monath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Excler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Gurwith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Bok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denny","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Michael Hendry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-519X","authenticated-orcid":false,"given":"Vidisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Mac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3094-8367","authenticated-orcid":false,"given":"Robert T.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.04.060_bib0395","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vaccine.2014.09.035","article-title":"The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)","volume":"33","author":"Chen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0400","series-title":"WHO informal consultation on characterization and quality aspect of vaccines based on live viral vectors","author":"World Health Organization","year":"2003"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0405","series-title":"WHO informal consultation: development of viral vectored vaccines for HIV, malaria, tuberculosis and other indications","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0410","series-title":"Guideline on quality, non-clinical and clinical aspects of live recombinant viral vectored vaccines","author":"European Medicines Agency","year":"2010"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0415","series-title":"Determining the need for and content of environmental assessments for gene therapies, vectored vaccines, and related recombinant viral or microbial products; guidance for industry","author":"U.S. Food and Drug Administration","year":"2015"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0420","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1517\/14712598.2012.704908","article-title":"Clinical development of IMOJEV (R) \u2013 a recombinant Japanese encephalitis chimeric vaccine (JE-CV)","volume":"12","author":"Appaiahgari","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0425","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0430","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0435","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0440","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","article-title":"Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections","volume":"20","author":"Monath","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0445","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/CMR.00005-07","article-title":"Current status of veterinary vaccines","volume":"20","author":"Meeusen","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0450","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1128\/JVI.00337-07","article-title":"Evidence of intragenic recombination in G1 rotavirus VP7 genes","volume":"81","author":"Phan","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0455","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/emboj\/21.6.1497","article-title":"Transfection-mediated generation of functionally competent Tula hantavirus with recombinant S RNA segment","volume":"21","author":"Plyusnin","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0460","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-3527(08)60795-2","article-title":"Genomic segment reassortment in rotaviruses and other reoviridae","volume":"39","author":"Ramig","year":"1991","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0465","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev.genet.36.052402.152757","article-title":"Genetics of influenza viruses","volume":"36","author":"Steinhauer","year":"2002","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0470","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-5793(98)00415-3","article-title":"Intragenic recombinations in rotaviruses","volume":"427","author":"Suzuki","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0475","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.virol.2007.09.038","article-title":"Identification of a natural multi-recombinant of Newcastle disease virus","volume":"371","author":"Han","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0480","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1471-2180-9-260","article-title":"Multiple recombinants in two dengue virus, serotype-2 isolates from patients from Oaxaca, Mexico","volume":"9","author":"Perez-Ramirez","year":"2009","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0485","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00705-008-0090-1","article-title":"Identification of a recombinant dengue virus type 1 with 3 recombination regions in natural populations in Guangdong province, China","volume":"153","author":"Chen","year":"2008","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0490","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1099\/vir.0.020818-0","article-title":"How RNA viruses maintain their genome integrity","volume":"91","author":"Barr","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0495","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1073\/pnas.85.16.5997","article-title":"Western equine encephalitis virus is a recombinant virus","volume":"85","author":"Hahn","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0500","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1128\/JVI.66.7.4457-4463.1992","article-title":"Effect of gamma radiation on retroviral recombination","volume":"66","author":"Hu","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0505","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0042-6822(87)90413-2","article-title":"Multiple recombination sites at the 5\u2032-end of murine coronavirus RNA","volume":"156","author":"Keck","year":"1987","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0510","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0092-8674(86)90600-8","article-title":"The mechanism of RNA recombination in poliovirus","volume":"47","author":"Kirkegaard","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0515","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/MMBR.56.1.61-79.1992","article-title":"RNA recombination in animal and plant viruses","volume":"56","author":"Lai","year":"1992","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0520","first-page":"21","article-title":"Genetic recombination in RNA viruses","volume":"176","author":"Lai","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"issue":"Pt 10","key":"10.1016\/j.vaccine.2016.04.060_bib0525","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1099\/0022-1317-80-10-2535","article-title":"Evolutionary aspects of recombination in RNA viruses","volume":"80","author":"Worobey","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0530","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1099\/vir.0.83122-0","article-title":"Multiple recombinant dengue type 1 viruses in an isolate from a dengue patient","volume":"88","author":"Aaskov","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0535","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.virol.2009.08.030","article-title":"Experimental evidence that RNA recombination occurs in the Japanese encephalitis virus","volume":"394","author":"Chuang","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0540","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1099\/vir.0.18660-0","article-title":"The extent of homologous recombination in members of the genus Flavivirus","volume":"84","author":"Twiddy","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0545","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1099\/vir.0.19277-0","article-title":"Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses","volume":"84","author":"Chare","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0550","series-title":"Comprehensive virology","first-page":"133","article-title":"Genetics of picornaviruses","author":"Cooper","year":"1977"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0555","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.virusres.2012.06.015","article-title":"The origin of genetic diversity in HIV-1","volume":"169","author":"Smyth","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0560","doi-asserted-by":"crossref","first-page":"7133","DOI":"10.1128\/JVI.00437-15","article-title":"Recombination of globally circulating varicella-zoster virus","volume":"89","author":"Norberg","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0565","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3855\/jidc.258","article-title":"When good vaccines go wild: Feral Orthopoxvirus in developing countries and beyond","volume":"2","author":"Moussatche","year":"2008","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0570","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/vr.153.7.209","article-title":"Isolation of a glycoprotein E-deleted bovine herpesvirus type 1 strain in the field","volume":"153","author":"Dispas","year":"2003","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0575","doi-asserted-by":"crossref","first-page":"e1000872","DOI":"10.1371\/journal.ppat.1000872","article-title":"The effect of vaccination on the evolution and population dynamics of avian paramyxovirus-1","volume":"6","author":"Chong","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0580","first-page":"16","article-title":"Circulating vaccine-derived polioviruses: current state of knowledge","volume":"82","author":"Kew","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0585","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.3201\/eid1712.111035","article-title":"Molecular epidemiology of Rift Valley fever virus","volume":"17","author":"Grobbelaar","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0590","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1128\/JVI.75.14.6256-6264.2001","article-title":"RNA recombination between persisting pestivirus and a vaccine strain: generation of cytopathogenic virus and induction of lethal disease","volume":"75","author":"Becher","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0595","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3201\/eid1704.101146","article-title":"Genome sequence of SG33 strain and recombination between wild-type and vaccine myxoma viruses","volume":"17","author":"Camus-Bouclainville","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0600","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1128\/JVI.01341-12","article-title":"Complete genome sequence of a novel variant porcine reproductive and respiratory syndrome virus (PRRSV) strain: evidence for recombination between vaccine and wild-type PRRSV strains","volume":"86","author":"Wenhui","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0605","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.1217134","article-title":"Attenuated vaccines can recombine to form virulent field viruses","volume":"337","author":"Lee","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0610","doi-asserted-by":"crossref","first-page":"e1001642","DOI":"10.1371\/journal.pbio.1001642","article-title":"The extraordinary evolutionary history of the reticuloendotheliosis viruses","volume":"11","author":"Niewiadomska","year":"2013","journal-title":"PLoS Biol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0615","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1371\/journal.pntd.0000549","article-title":"Oral rabies vaccination in north america: opportunities, complexities, and challenges","volume":"3","author":"Slate","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0620","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1016\/j.vaccine.2004.11.069","article-title":"Recombination and flavivirus vaccines: a commentary","volume":"23","author":"Monath","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0625","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(04)16459-3","article-title":"Live flavivirus vaccines: reasons for caution","volume":"363","author":"Seligman","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0630","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/590915","article-title":"Safety concerns with regard to live attenuated flavivirus vaccines","volume":"198","author":"Seligman","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0635","doi-asserted-by":"crossref","first-page":"9805","DOI":"10.1128\/JVI.01336-08","article-title":"What are the risks \u2013 hypothetical and observed \u2013 of recombination involving live vaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses?","volume":"82","author":"Collins","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0640","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1128\/JVI.00370-08","article-title":"Caution about Newcastle disease virus-based live attenuated vaccine","volume":"82","author":"Han","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0645","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1128\/JVI.00609-11","article-title":"A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains","volume":"85","author":"Hai","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0650","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.1128\/JVI.00738-06","article-title":"Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity","volume":"80","author":"Mueller","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0655","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1126\/science.1155761","article-title":"Virus attenuation by genome-scale changes in codon pair bias","volume":"320","author":"Coleman","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0660","doi-asserted-by":"crossref","first-page":"e27837","DOI":"10.1371\/journal.pone.0027837","article-title":"Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B\/E vaccination in an efficacy trial in Thailand","volume":"6","author":"Pitisuttithum","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0665","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1128\/JVI.73.6.4705-4712.1999","article-title":"Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus","volume":"73","author":"Ball","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0670","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1128\/JVI.01911-06","article-title":"Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations","volume":"81","author":"Clarke","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0675","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1128\/JVI.03441-13","article-title":"Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates","volume":"88","author":"Clarke","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0680","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.virol.2005.09.020","article-title":"Replication-defective viruses as vaccines and vaccine vectors","volume":"344","author":"Dudek","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0685","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/422258","article-title":"Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults","volume":"190","author":"Nitayaphan","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0690","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0264-410X(95)00171-V","article-title":"Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system","volume":"14","author":"Fries","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0695","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1016\/j.vaccine.2013.03.020","article-title":"Clinical development of Modified Vaccinia virus Ankara vaccines","volume":"31","author":"Gilbert","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0700","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1089\/104303403766682278","article-title":"Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses","volume":"14","author":"Youil","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0705","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/JVI.75.3.1205-1210.2001","article-title":"Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox","volume":"75","author":"Jackson","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0710","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.virol.2010.10.021","article-title":"Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy","volume":"409","author":"Chen","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0715","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2013.03.025","article-title":"Genomic analysis of vaccinia virus strain TianTan provides new insights into the evolution and evolutionary relationships between Orthopoxviruses","volume":"442","author":"Qin","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0720","doi-asserted-by":"crossref","first-page":"e68115","DOI":"10.1371\/journal.pone.0068115","article-title":"Deletion of C7L and K1L genes leads to significantly decreased virulence of recombinant vaccinia virus TianTan","volume":"8","author":"Liu","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0725","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/QAD.0000000000000595","article-title":"HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection","volume":"29","author":"Liu","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0730","doi-asserted-by":"crossref","first-page":"e83274","DOI":"10.1371\/journal.pone.0083274","article-title":"A replicating modified vaccinia tiantan strain expressing an avian-derived influenza H5N1 hemagglutinin induce broadly neutralizing antibodies and cross-clade protective immunity in mice","volume":"8","author":"Xiao","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0735","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/mt.2013.122","article-title":"The novel replication-defective vaccinia virus (Tiantan strain)-based hepatitis C virus vaccine induces robust immunity in macaques","volume":"21","author":"Wen","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0740","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1473-3099(12)70345-6","article-title":"Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study","volume":"13","author":"Gurwith","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0745","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/cid\/ciu507","article-title":"Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines","volume":"59","author":"Radin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0750","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4161\/hv.27238","article-title":"Vaccines within vaccines: the use of adenovirus types 4 and 7 as influenza vaccine vectors","volume":"10","author":"Weaver","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0755","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0760","doi-asserted-by":"crossref","first-page":"e23247","DOI":"10.1371\/journal.pone.0023247","article-title":"Stability of yellow fever virus under recombinatory pressure as compared with chikungunya virus","volume":"6","author":"McGee","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0765","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1128\/JVI.01063-09","article-title":"A trans-complementing recombination trap demonstrates a low propensity of flaviviruses for intermolecular recombination","volume":"84","author":"Taucher","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0770","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/527328","article-title":"Substitution of wild-type yellow fever Asibi sequences for 17D vaccine sequences in ChimeriVax-dengue 4 does not enhance infection of Aedes aegypti mosquitoes","volume":"197","author":"McGee","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0775","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/527329","article-title":"Recombinant chimeric virus with wild-type dengue 4 virus premembrane and envelope and virulent yellow fever virus Asibi backbone sequences is dramatically attenuated in nonhuman primates","volume":"197","author":"McGee","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.060_bib0780","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.vaccine.2014.10.004","article-title":"Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk\/benefit assessment","volume":"33","author":"Monath","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T11:38:57Z","timestamp":1582544337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16302250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":78,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X16302250"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}